1                                              RPGN benefits from high-dose steroids and cytotoxic drug

2                                In crescentic RPGN the role of cellular rather than humoral immune mec

3 tion as a potential therapeutic strategy for RPGN.

4 is/idiopathic crescentic glomerulonephritis (RPGN/ICG), IgA nephropathy (IgA), mesangioproliferative

5 ntic rapidly progressive glomerulonephritis (RPGN) represents the most aggressive form of acquired gl

6 thy, rapidly progressive glomerulonephritis (RPGN), and membranoproliferative glomerulonephritis (MPG

7 p57(Kip2) and prevented glomerular injury in RPGN.

8                           An exception is in RPGN where podocytes undergo a deregulation of their dif

9 iched in podocytes of patients and mice with RPGN.